Skip to main content
MDLN
NASDAQ Industrial Applications And Services

Medline Q3 Sales Rise 10.4% to $7.86B; Nine-Month Net Income Drops 28.8% on Fire and FDA Costs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$40.35
Mkt Cap
$53.048B
52W Low
$31.37
52W High
$50.876
52W Position info
29% above low
Off High info
21% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

MDLN sits 29% above its 52-week low of $31.37 on elevated volume (2.9× avg).

Summary

Medline grew Q3 sales 10.4% to $7.86 billion, but nine-month net income fell 28.8% to $696 million on Tracy fire losses and tariff costs. The filing also discloses three unresolved FDA warning letters and a $60M-$210M bed-recall cost estimate.


Key Events · Earnings and Guidance · MDLN

  • Q3 Sales Grow 10.4% to $7.86B

    Net sales rose to $7,856 million from $7,115 million, driven by Prime Vendor volume growth; nine-month sales reached $22,893 million, up 10.9%.

  • Nine-Month Net Income Down 28.8%

    Net income fell to $696 million from $977 million as other operating expenses jumped to $353 million from $30 million, largely $416 million of Tracy fire losses net of $100 million insurance recoveries. Q3 net income was $318 million and diluted EPS $0.22.

  • FDA Warning Letters Unresolved

    Three FDA warning letters (Northfield IL, Glens Falls NY, Waukegan IL) remain open, and the Medline Brand bed exit carries an estimated $60 million-$210 million of incremental costs in Q4 2026 and 2027.

  • $1B Buyback and $750M Debt Prepayment

    The board authorized repurchases of up to $1 billion of Class A stock and/or Medline Holdings units in October 2026, with none executed yet. The company also prepaid $750 million of the 2033 Refinancing Term Loan on October 22, 2026, booking a ~$21 million Q4 extinguishment loss.


Analysis · MDLN · Industrial Applications And Services

Top-line momentum remains intact: Q3 sales rose 10.4% to $7.86 billion, and nine-month sales climbed 10.9% to $22.9 billion on Prime Vendor volume growth. Profitability, however, is eroding. Nine-month net income fell 28.8% to $696 million as $416 million of Tracy fire losses (net of $100 million insurance) and higher tariff-driven import costs hit the P&L, and gross margin slipped to 26.1% from 27.1%. The filing also hard-codes the quality overhang: three unresolved FDA warning letters and a Medline Brand bed exit now estimated at $60 million-$210 million of incremental cost. Against that, the company authorized a $1 billion buyback in October and prepaid $750 million of term debt, which supports the stock but does not offset the margin and regulatory pressure.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDLN was trading at $40.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $53B. The 52-week trading range was $31.37 to $50.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Nov 18, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $39.16
Real-time Price: $39.20 info
Change: +$0.040 (+0.10%) info
Market Cap: $51.521B info
MDLN
Nov 17, 2026, 10:23 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $37.51
Real-time Price: $39.20 info
Change: +$1.69 (+5%) info
Market Cap: $51.521B info
MDLN
Nov 16, 2026, 6:42 AM EST
Filing Type: S-1
Importance Score:
8
Price at Filing: $39.24
Real-time Price: $39.20 info
Change: -$0.0374 (-0.10%) info
Market Cap: $51.521B info
MDLN
Nov 13, 2026, 4:58 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.82
Real-time Price: $39.20 info
Change: -$0.6159 (-2%) info
Market Cap: $51.521B info
MDLN
Nov 04, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.15
Real-time Price: $39.20 info
Change: +$2.05 (+6%) info
Market Cap: $51.521B info